This compound is a brominated quinazoline derivative used as a pharmaceutical impurity reference standard, specifically for the quality control of ambroxol. It serves as an analytical marker for detecting and quantifying related impurities in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2088879-81-4
Trans-4-(6,8-Dibromoquinazolin-3(4H)-yl)cyclohexanol hydrochloride Ambroxol Impurity
pharmaceutical intermediate
Ambroxol Cycloimine Impurity
pharmaceutical raw material
Enzalutamide Impurity 56
pharmaceutical intermediate
3-methyl-5-phenoxy-1(3h)-isobenzofuranone
pharmaceutical intermediate
Methyl 3-[[4-Chloro-2-(phenylamino)phenyl]methylamino]-3-oxopropanoate
pharmaceutical intermediate
SM-102
pharmaceutical intermediate
4-(6,8-dibromo-4H-quinazolin-3-yl)cyclohexan-1-ol
ARMLBUAMNBQDHJ-UHFFFAOYSA-N
C1CC(CCC1N2CC3=C(C(=CC(=C3)Br)Br)N=C2)O